Study on safety and bioavailability of ubiquinol (Kaneka QH™) after single and 4-week multiple oral administration to healthy volunteers

Effects of Coenzyme Q10 in Early Parkinson Disease

Clifford W. Shults · Archives of Neurology · 2002 · 977 citations

Medicine, Pharmacology, Pharmacotherapy +17

Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.

Balz Frei, M C Kim, B N Ames · Proceedings of the National Academy of Sciences · 1990 · 619 citations

Life Sciences, Biochemistry, Cell Biology +17

Distribution and redox state of ubiquinones in rat and human tissues

Fredrik Åberg, Eeva‐Liisa Appelkvist, Gustav Dallner et al. · Archives of Biochemistry and Biophysics · 1992 · 314 citations

Life Sciences, Biochemistry, Molecular Biology +14

Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation

Detlef Mohr, Vincent W. Bowry, Roland Stocker · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · 1992 · 313 citations

Life Sciences, Biochemistry, Nutritional Sciences +11

Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease

Clifford W. Shults, M. Flint Beal, David Song et al. · Experimental Neurology · 2004 · 221 citations

Medicine, Neurology, Pharmacology +13